Authorities have requested from Nancy Guthrie's neighbors that they report and submit video of any suspicious activity between January 1 and February 2, as they continue to search for the mother of ...

The in-development feature reported by @nima_owji shows a toggle that allows users to disclose synthetically made or manipulated content. The move may be in response to India ordering social platforms ...

I didn’t come to zero-gravity sleeping out of need. It was more of a “why not?” My Bedgear adjustable bed frame, which I’ve owned for years, has a “zero gravity” preset. I’d used it occasionally to ...

Grocery store private labels are big business—with groceries more expensive than ever, shoppers are making every effort to save on their bills, and switching from big brand names to "own-brand" just ...

I was impressed with foveated streaming on the Steam Frame, which, when you’re interacting with games streamed to the headset, renders what’s right in front of your eyes at the highest fidelity. I ...

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a management update and financial results for the fourth quarter and full year of 2025 ...

WSJ’s Shelby Holliday explains the massive U.S. military presence in the Middle East as President Trump amps up pressure on Iran over its nuclear program. Illustration: Ryan Trefes WASHINGTON—The U.S.

Ascendis Pharma (ASND) reported its fourth-quarter 2025 financial results, revealing a wider-than-expected loss per share and a slight miss on revenue forecasts. The company posted an earnings per ...

Thank you for standing by, and welcome to the Ascendis Pharma Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded. And now I'd like ...

Good morning. My name is Rob, and I will be your conference operator today. I would like to welcome everyone to the call. [Operator Instructions] I'd now like to introduce Beth DelGiacco, Vice ...

Earnings call Ascendis reported FY2025 revenue of EUR 720M, up significantly YoY, with Q4 revenue at EUR 248M. YORVIPATH led with EUR 477M in annual sales, followed by SKYTROFA at EUR 206M. Management ...